Mk. Hellerstein et al., MODEL FOR MEASURING ABSOLUTE RATES OF HEPATIC DE-NOVO LIPOGENESIS ANDREESTERIFICATION OF FREE FATTY-ACIDS, The American journal of physiology, 265(5), 1993, pp. 50000814-50000820
We have previously presented a precursor-product stable isotopic techn
ique for measuring in vivo the fraction of very low-density lipoprotei
n-fatty acids (VLDL-FA) derived from de novo lipogenesis (fractional D
NL). Here, we propose a technique for converting fractional DNL into a
bsolute rates of DNL and describe its explicit underlying assumptions.
The technique combines the fractional DNL method with a modification
of the method of S. Klein, V. R. Young, G. L. A. Blackburn, B. R. Bist
rian, and R. R. Wolfe (J. Clin. Invest. 78: 928-933, 1986), for estima
ting hepatic reesterification of free fatty acids (FFA). Infusions of
[1,2,3,4-C-13]palmitate and [1-C-13]acetate are performed concurrently
with indirect calorimetry in human subjects. Fractional DNL (based on
mass isotopomer distribution analysis of VLDL-FA), the rate of appear
ance of plasma FFA (R(a) of FFA), and net fat oxidation in the whole b
ody are measured. Equations from the hepatic reesterification model, m
odified to include the contribution from DNL, allow calculation of abs
olute DNL (= fractional DNL x [R(a) of FFA - net whole body fat oxidat
ion], when respiratory quotient < 1.0). Sample results from human subj
ects with different dietary energy intakes are presented, with calcula
tions of absolute DNL, absolute reesterification, and absolute fat oxi
dation rates. The assumptions of this technique (in particular, that a
ll fat oxidized is derived at steady state from circulating FFA and th
at DNL and reesterification of FFA both occur exclusively in liver) ar
e discussed. In summary, by combining a fatty acid turnover-indirect c
alorimetric technique (to estimate net oxidation and reesterification
rates) with a precursor incorporation method (to measure fractional DN
L), absolute rates of fat synthesis, fat oxidation, and fatty acid ree
sterification can be quantified in humans. Validation of this approach
depends on experimental testing of the assumptions noted.